News

News
Partner news

Lava Therapeutics Announces Collaboration with Janssen to Develop Bi-specific Gamma-Delta T-cell Engager Therapeutics

Read full story
Partner news

Philogen Announces Options Exercise by Janssen

Read full story
Partner news

RefleXion Raises $100 Million for Cancer Treatment Commercialization

Read full story
Partner news

Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies

Read full story
Partner news

Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform

Read full story
Partner news

OrthoSpin Ltd. Raises up to US$5 Million in Series B Financing

Read full story
Partner news

FDA Clearance Brings RefleXion Closer to Expanding Cancer Treatment Market

Read full story
Partner news

BlackThorn Therapeutics Advances Phase 2 Clinical Development for Selective KOR Antagonist, BTRX-140, in Neuropsychiatric Disorders

Read full story
Partner news

Concerto HealthAI Establishes Real-World Data and AI Collaboration with Janssen

Read full story
Partner news

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)

Read full story
Partner news

Johnson & Johnson Acquires TARIS Biomedical with Focus on Transforming the Treatment of Bladder Cancer

Read full story
Partner news

Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.

Read full story
Partner news

Zebra Medical Vision Announces Agreement With DePuy Synthes to Deploy Cloud Based Artificial Intelligence Orthopaedic Surgical Planning Tools

Read full story
In the media

At the Bio-Europe conference in Hamburg last month, experts weighed in on the challenges and future of neuroscience

Read full story
Partner news

Janssen to Acquire Investigational Bermekimab from XBiotech

Read full story